Wolfe Research analyst Andy Chen initiated coverage of AnaptysBio (ANAB) with an Outperform rating.Maximize Your Portfolio with Data Driven ...
Wolfe Research analyst Andy Chen initiated coverage of Oruka Therapeutics (ORKA) with an Outperform rating.Maximize Your Portfolio with Data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback